dafa888bet手游下载,dafa888bet手游网址,dafa888betpt老虎机网址

Stock(600222) Hot line:010-61006450

CMC

Committed to the development and innovation of first-class drugs

API R&D Platform

The API and Excipients R&D Platform relies on multiple high-tech platforms and a strong technical development team, which integrates R&D, registration, production and sales functions. It can provide customized synthesis of advanced intermediates, API, impurities, etc., as well as quality research, green production process development, registration and declaration of API.

We has built high-end API and excipient development bases in Miyun and Chongqing, covering an area of more than 2000㎡, which can meet the requirements for the preparation and production of 0.1 kilograms to several kilograms products in the laboratory, and can undertake research on high-end excipient imitation and substitution projects.